Indication

Mottle hyperpigmentation

Mottle hyperpigmentation (often referred to clinically as mottled hyperpigmentation) is a dermatologic sign characterized by irregular, patchy, or variegated macules of increased skin pigmentation. Read more about Mottle hyperpigmentation

5 drugs 4 manufacturers

Advertisement

Drugs that treat it

Common Mottle hyperpigmentation therapies.

Showing 1–5 of 5 drugs

Filter & compare in the drug finder →Opens the drug finder with Mottle hyperpigmentation preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Mottle hyperpigmentation.

Mottle hyperpigmentation (often referred to clinically as mottled hyperpigmentation) is a dermatologic sign characterized by irregular, patchy, or variegated macules of increased skin pigmentation.

Commonly affecting sun-exposed areas of the integumentary system—such as the face, neck, and dorsal hands—it predominantly arises in photoaged populations or as a component of postinflammatory dyschromia, though it can also manifest in certain hereditary reticulate pigmentary disorders.

Pathophysiologically, the condition is driven by UV-induced or inflammatory stimulation of melanocytes, resulting in hyperactive melanogenesis, aberrant melanin synthesis, and the uneven accumulation of melanin within epidermal keratinocytes or dermal melanophages.

Personalize your experience

Follow Mottle hyperpigmentation and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it